RxDoctor Payments Data

Katrina Carlson

Nurse Practitioner · Lagrange, INNPI 1740719244

Payments from drug & device makers

$1,090in general payments, 2019–2025

Across 61 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$247
  • AbbVie$205
  • Lilly USA, LLC$125
  • Takeda Pharmaceuticals U.S.A., Inc.$107
  • Exact Sciences$78
  • Amgen$60
  • plus $268 from 9 others

What the payments were for

  • Food & beverage$1,090100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,090 in reported general payments places this provider in the 75th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$22,246
Medicare patients
98
Services billed
374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide50$71,173
MounjaroTirzepatide26$33,962
JardianceEmpagliflozin22$33,020
EliquisApixaban20$28,696
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$27,819
TradjentaLinagliptin23$25,251
Breo ElliptaFluticasone/Vilanterol24$11,412
Albuterol Sulfate HfaAlbuterol Sulfate64$1,731
Levothyroxine Sodium220$1,461
Omeprazole98$1,242
Gabapentin76$1,037
Lisinopril203$999
Bupropion XlBupropion Hcl54$989
Duloxetine Hcl37$817
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$775

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$56$71,17350 claims
Boehringer IngelheimJardiance, Tradjenta$247$58,27145 claims
GSKTrelegy Ellipta, Breo Ellipta$55$39,23048 claims
Lilly USA, LLCMounjaro$125$33,96226 claims
PfizerEliquis$18$28,69620 claims
AbbVieSynthroid$205$23820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Lagrange

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →